Latest Module Specifications
Current Academic Year 2025 - 2026
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Description Students will be introduced to the concepts of drug design and development including the use of computational modelling. Concepts related to both drug delivery, pro-drugs and hybrid drug molecules are also described. Advanced topics relating to modern drug development will also be covered with emphasis on drug design, solid-form development, clinical trials and final marketing using specific drug examples from the last 15 years. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Learning Outcomes 1. Understand the principles of radiopharaceutical design and MRI contrast agents 2. Understand the principles of nucleic acid drugs and antisense therapeutics 3. Prodrug design and applications 4. Introduction to drug delivery 5. Drug design including fragment approaches, QSAR and 3D QSAR with specific examples. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Indicative Content and Learning Activities
Pharmaceutical solid form development Polymorphism, salts, hydrates, co-crystals; Solid-form risk assessment, solid-form properties regulation of solid forms (ICH 6 & 9); Experimental and computational screening for solid forms, case studies. Computational chemistry in drug development Key computational approaches for modelling molecules (ab initio, force fields etc.); conformational analysis of APIs; basic principles of docking. Radiopharmaceuticals and contrast agents Metal complexes in disease diagnostics, radiopharmaceuticals, magnetic resonance imaging, SPECT, PET, tracer design Nucleic acid drugs Antisense therapeutics, gene editing, nucleic acid chemistry, hybrid nucleic acid drugs, nucleic acid chemistry | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Indicative Reading List Books:
Articles: None | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Resources None | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||